Arianna Bertolani

449 total citations
19 papers, 340 citations indexed

About

Arianna Bertolani is a scholar working on Economics and Econometrics, Immunology and Physiology. According to data from OpenAlex, Arianna Bertolani has authored 19 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 5 papers in Immunology and 4 papers in Physiology. Recurrent topics in Arianna Bertolani's work include Health Systems, Economic Evaluations, Quality of Life (10 papers), Pharmaceutical Economics and Policy (7 papers) and Biosimilars and Bioanalytical Methods (5 papers). Arianna Bertolani is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (10 papers), Pharmaceutical Economics and Policy (7 papers) and Biosimilars and Bioanalytical Methods (5 papers). Arianna Bertolani collaborates with scholars based in Italy, Finland and France. Arianna Bertolani's co-authors include Claudio Jommi, Carla Rognoni, Pierangelo Metrangolo, Francesco Costa, Patrizio Armeni, Giancarlo Terraneo, Lisa Pirrie, Andrea Pizzi, Giuseppe Resnati and Francesco Molinari and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Chemistry - A European Journal.

In The Last Decade

Arianna Bertolani

19 papers receiving 335 citations

Peers

Arianna Bertolani

MB

BIOMA

EE

PTC

PHYSI

M. Visconti Italy

J. E. Hansen United States

F. Somers Belgium

Daisuke Ohta Japan

Frederick B. Loiselle Canada

Aloka Srinivasan United States

T Takino Japan

Yoshifumi Yamada Japan

Hongyan Zhang China

T. Dung United States

M. Visconti Italy

Arianna Bertolani

78 ×0.6

MB

12 ×0.1

BIOMA

10 ×0.1

EE

28 ×0.5

PTC

15 ×0.3

PHYSI

Citations per year, relative to Arianna Bertolani Arianna Bertolani (= 1×) peers M. Visconti

Countries citing papers authored by Arianna Bertolani

Since Specialization

Citations

This map shows the geographic impact of Arianna Bertolani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arianna Bertolani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arianna Bertolani more than expected).

Fields of papers citing papers by Arianna Bertolani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arianna Bertolani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arianna Bertolani. The network helps show where Arianna Bertolani may publish in the future.

Co-authorship network of co-authors of Arianna Bertolani

This figure shows the co-authorship network connecting the top 25 collaborators of Arianna Bertolani. A scholar is included among the top collaborators of Arianna Bertolani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arianna Bertolani. Arianna Bertolani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Giannuzzi, Viviana, Arianna Bertolani, Silvia Torretta, et al.. (2024). Innovative research methodologies in the EU regulatory framework: an analysis of EMA qualification procedures from a pediatric perspective. Frontiers in Medicine. 11. 1369547–1369547. 2 indexed citations

2.

Jommi, Claudio, et al.. (2023). Pharmaceutical pricing and managed entry agreements: An exploratory study on future perspectives in Europe. Health Policy and Technology. 12(3). 100771–100771. 6 indexed citations

3.

Bertolani, Arianna, et al.. (2022). The costs incurred by patients to get eligibility to PCSK9 treatment and one-year follow-up: the results of the PRIOR Study. SHILAP Revista de lepidopterología. 9. 73–81. 1 indexed citations

4.

Jommi, Claudio, et al.. (2021). The future of Funds for Innovative Medicines: results from a Delphi Study. SHILAP Revista de lepidopterología. 8. 22–28. 5 indexed citations

5.

Rognoni, Carla, Arianna Bertolani, & Claudio Jommi. (2021). Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects. Clinical Drug Investigation. 41(4). 303–319. 49 indexed citations

6.

Jommi, Claudio & Arianna Bertolani. (2020). PBI35 Local Policies on Biosimilars: Are They Designed to Optimize Use of Freed Resources?. Value in Health. 23. S416–S416. 1 indexed citations

7.

Bertolani, Arianna & Claudio Jommi. (2020). Local policies on biosimilars: are they designed to optimize use of liberated resources?. Generics and Biosimilars Initiative Journal. 9(4). 163–170. 2 indexed citations

8.

Jommi, Claudio, et al.. (2019). Implementation of Value-based Pricing for Medicines. Clinical Therapeutics. 42(1). 15–24. 51 indexed citations

9.

Bertolani, Arianna, Giovanni Fattore, & F. Pregliasco. (2018). The hospitalization burden of influenza: just the tip of the iceberg?. Global & Regional Health Technology Assessment. 5(1). 1 indexed citations

10.

Rognoni, Carla, Arianna Bertolani, & Claudio Jommi. (2018). Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives. Global & Regional Health Technology Assessment. 5(1). 2 indexed citations

11.

Bertolani, Arianna, Giovanni Fattore, & F. Pregliasco. (2018). The hospitalization burden of influenza: just the tip of the iceberg?. Global & Regional Health Technology Assessment. 2018. 491207250–491207250. 6 indexed citations

12.

Rognoni, Carla, Arianna Bertolani, & Claudio Jommi. (2018). Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives. Global & Regional Health Technology Assessment. 2018. 491207964–491207964. 8 indexed citations

13.

Jommi, Claudio & Arianna Bertolani. (2018). Patients’ Associations and HTA for medicines: actual and future role in Italy. Global & Regional Health Technology Assessment. 2018. 491206632–491206632. 2 indexed citations

14.

Pizzi, Andrea, Luisa Lascialfari, Nicola Demitri, et al.. (2017). Halogen bonding modulates hydrogel formation from Fmoc amino acids. CrystEngComm. 19(14). 1870–1874. 39 indexed citations

15.

Bertolani, Arianna, Andrea Pizzi, Lisa Pirrie, et al.. (2016). Crystal Structure of the DFNKF Segment of Human Calcitonin Unveils Aromatic Interactions between Phenylalanines. Chemistry - A European Journal. 23(9). 1985–1985. 1 indexed citations

16.

Bertolani, Arianna, Andrea Pizzi, Lisa Pirrie, et al.. (2016). Crystal Structure of the DFNKF Segment of Human Calcitonin Unveils Aromatic Interactions between Phenylalanines. Chemistry - A European Journal. 23(9). 2051–2058. 32 indexed citations

17.

Bertolani, Arianna, Lisa Pirrie, Loïc Stefan, et al.. (2015). Supramolecular amplification of amyloid self-assembly by iodination. Nature Communications. 6(1). 7574–7574. 89 indexed citations

18.

Tamborini, Lucia, Diego Romano, Andrea Pinto, et al.. (2012). An efficient method for the lipase-catalysed resolution and in-line purification of racemic flurbiprofen in a continuous-flow reactor. Journal of Molecular Catalysis B Enzymatic. 84. 78–82. 42 indexed citations

19.

Bertolani, Arianna. (1952). [Geriatrics and neuropsychiatry].. PubMed. 76(4). 681–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact